CODX vs CPT
Co-Diagnostics, Inc. Common Stock (CODX) versus Camden Property Trust (CPT) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
CODX currently screens at market cap $31.4M. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Not investment advice. Open the CODX and CPT stock pages for the full models.
Not investment advice.